Evidence map›Paper›PMID 35148384›Full record

ArticleBrain : a journal of neurology2022

Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's disease.

Leticia Peris, Julie Parato, Xiaoyi Qu, Jean Marc Soleilhac, Fabien Lanté, Atul Kumar, Maria Elena Pero, José Martínez-Hernández, Charlotte Corrao, Giulia Falivelli and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Kinetochore proteins control microtubule dynamics in postmitotic neurons to regulate the formation of dendritic spines.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Review
  7. Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer's Disease.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  8. Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transition in lung cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 3 countries.

Leticia PerisUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0002-0668-1252
Julie ParatoDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Xiaoyi QuDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Jean Marc SoleilhacUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0001-8072-8496
Fabien LantéUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0002-3845-7044
Atul KumarDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Maria Elena PeroDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
José Martínez-HernándezUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0002-5017-2877
Charlotte CorraoUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.
Giulia FalivelliUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.
Floriane PayetUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.
Sylvie Gory-FauréUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0001-5743-8079
Christophe BoscUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0002-3195-6692
Marian Blanca RamirezDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Andrew SproulDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.ORCID 0000-0001-6972-1592
Jacques BrocardUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0002-0752-5737
Benjamin Di CaraInstitut de Recherche Servier, Croissy, France.
Philippe DelagrangeInstitut de Recherche Servier, Croissy, France.
Alain BuissonUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0002-4281-7911
Yves GoldbergUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0001-7446-8595
Marie Jo MoutinUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0003-2681-9818
Francesca BartoliniDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.ORCID 0000-0003-1048-622X
Annie AndrieuxUniv. Grenoble Alpes, Inserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France.ORCID 0000-0002-4022-6405
Centre National de la Recherche Scientifique · FRColumbia University Irving Medical Center · USAVL (France) · FR

Funding

Pathogenic Roles for Microtubule Stabilization Pathways in Alzheimers diseaseR01AG050658 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Francesca Bartolini · 2016 to 2026
$3.5M
Pathogenic Roles for Microtubule Stabilization Pathways in Alzheimer's DiseaseR56AG050658 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARTOLINI, FRANCESCA · 2021 to 2021
$755k
Pathogenic Role of D2 tubulin in Peripheral NeuropathyR21NS120076 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARTOLINI, FRANCESCA · 2020 to 2020
$446k
Formin-mediated stabilization of dynamic microtubules in the pathogenesis of early-onset familial Alzheimers diseaseR03AG060025 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARTOLINI, FRANCESCA · 2018 to 2019
$162k
NIA NIH HHS R01 AG050658NIA NIH HHS R03 AG060025NIA NIH HHS R56 AG050658NINDS NIH HHS R21 NS120076
6 · The paper itself

Abstract

Microtubules play fundamental roles in the maintenance of neuronal processes and in synaptic function and plasticity. While dynamic microtubules are mainly composed of tyrosinated tubulin, long-lived microtubules contain detyrosinated tubulin, suggesting that the tubulin tyrosination/detyrosination cycle is a key player in the maintenance of microtubule dynamics and neuronal homeostasis, conditions that go awry in neurodegenerative diseases. In the tyrosination/detyrosination cycle, the C-terminal tyrosine of α-tubulin is removed by tubulin carboxypeptidases and re-added by tubulin tyrosine ligase (TTL). Here we show that TTL heterozygous mice exhibit decreased tyrosinated microtubules, reduced dendritic spine density and both synaptic plasticity and memory deficits. We further report decreased TTL expression in sporadic and familial Alzheimer's disease, and reduced microtubule dynamics in human neurons harbouring the familial APP-V717I mutation. Finally, we show that synapses visited by dynamic microtubules are more resistant to oligomeric amyloid-β peptide toxicity and that expression of TTL, by restoring microtubule entry into spines, suppresses the loss of synapses induced by amyloid-β peptide. Together, our results demonstrate that a balanced tyrosination/detyrosination tubulin cycle is necessary for the maintenance of synaptic plasticity, is protective against amyloid-β peptide-induced synaptic damage and that this balance is lost in Alzheimer's disease, providing evidence that defective tubulin retyrosination may contribute to circuit dysfunction during neurodegeneration in Alzheimer's disease.

Indexed as

Alzheimer DiseaseTubulinAnimalsHumansMiceMicrotubulesPeptidesTyrosinePeptidesTubulinTyrosineAlzheimer’s diseasedendritic spinesmicrotubuleneurontubulin

Identifiers

PMID35148384
PMCPMC9337816
OpenAlexW4206406026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.